Keyphrases
Long QT Syndrome
57%
Gain-of-function mutation
43%
Atrial Fibrillation
41%
Early Onset
32%
Sodium Channel
31%
IKur
31%
Loss Function
28%
Receptor Activation
23%
Action Potential Duration
21%
G Protein-coupled
21%
Lone Atrial Fibrillation
21%
GIRK Channel
20%
Rare Variants
20%
Familial Atrial Fibrillation
20%
Congenital Long QT Syndrome
19%
Genetic Variation
18%
SCN5A mutation
18%
Ventricular Repolarization
17%
Channel Subunits
17%
Acetylcholine
17%
β Subunit
17%
SCN5A
17%
Functional Characterization
17%
Angiotensin II (Ang II)
15%
Angiotensin II Type 1 Receptor (AT1R)
15%
Fibrinolysis
15%
Phenotype Characteristics
15%
Brugada Syndrome
15%
Ventricular Tachycardia
15%
GIRK4
15%
Angioplasty
15%
KCNJ5
15%
In Silico Assessment
15%
Ischemia-reperfusion Injury
15%
Clopidogrel
15%
Kv1.1
15%
Atrial Flutter
15%
KCNH2
15%
KCNK3
15%
Atrial Substrate
15%
Two-pore Domain Potassium Channel
15%
KCNE2
15%
Multiple Mechanisms
15%
SCN3B
15%
Channel Activation
15%
Muscarinic Receptors
15%
High Prevalence
15%
KCNA5
15%
Common Variants
15%
Atrial Electrophysiology
15%
Biochemistry, Genetics and Molecular Biology
Atrial Fibrillation
100%
Genetic Divergence
49%
Genetic Variation
49%
Long QT Syndrome
48%
Gain of Function Mutation
38%
Familial Atrial Fibrillation
35%
Sodium Channel
34%
KCNA5
31%
Potassium Current
26%
Potassium Channel
25%
Patch Clamp
23%
Rare Variant
20%
Conductance
19%
Reperfusion
19%
Loss of Function Mutation
19%
Prevalence
19%
Beta Chain
17%
Angiotensin
15%
Brugada Syndrome
15%
KCNJ5
15%
Impaired Glucose Tolerance
15%
SCN3B
15%
Kir2.1
15%
KCNE2
15%
Fructose
15%
